ask="0.6300"
ask_size="8500"
average_daily_volume="2075000"
bid="0.6100"
bid_size="500"
book_value="0.1800"
change="+0.0109"
change_from_200_day_moving_average="-1.6138"
change_from_50_day_moving_average="-0.1648"
change_from_52_week_high="-4.3209"
change_From_52_week_low="0.0691"
change_in_percent="+1.9183%"
close="0.5791"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.4440"
ebitda="-49.68M"
eps_estimate_current_year="-1.5900"
eps_estimate_next_quarter="-0.3300"
eps_estimate_next_year="-1.2900"
ex_dividend_date="N/A"
float_shares="36794000"
high="0.5975"
high_52_weeks="4.9000"
last_trade_date="2/9/2017"
last_trade_price="0.5791"
last_trade_size="7040"
last_trade_time="4:00pm"
low="0.5415"
low_52_weeks="0.5100"
market_capitalization="24.30M"
moving_average_200_day="2.1930"
moving_average_50_day="0.7439"
name="Anthera Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="2.8500"
open="0.5778"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-73.5926%"
percent_change_from_50_day_moving_average="-22.1576%"
percent_change_from_52_week_high="-88.1816%"
percent_change_from_52_week_low="+13.5490%"
previous_close="0.5682"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.1567"
price_per_sales="11.5554"
revenue="2.06M"
shares_outstanding="41955000"
short_ratio="1.8300"
stock_exchange="NGM"
symbol="ANTH"
volume="694827"
weeks_range_52="0.5100 - 4.9000"
